These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33416451)

  • 1. New insight in understanding the contribution of SGLT1 in cardiac glucose uptake: evidence for a truncated form in mice and humans.
    Ferté L; Marino A; Battault S; Bultot L; Van Steenbergen A; Bol A; Cumps J; Ginion A; Koepsell H; Dumoutier L; Hue L; Horman S; Bertrand L; Beauloye C
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H838-H853. PubMed ID: 33416451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity.
    Yoshii A; Nagoshi T; Kashiwagi Y; Kimura H; Tanaka Y; Oi Y; Ito K; Yoshino T; Tanaka TD; Yoshimura M
    Cardiovasc Diabetol; 2019 Jul; 18(1):85. PubMed ID: 31262297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states.
    Banerjee SK; McGaffin KR; Pastor-Soler NM; Ahmad F
    Cardiovasc Res; 2009 Oct; 84(1):111-8. PubMed ID: 19509029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice.
    Kashiwagi Y; Nagoshi T; Yoshino T; Tanaka TD; Ito K; Harada T; Takahashi H; Ikegami M; Anzawa R; Yoshimura M
    PLoS One; 2015; 10(6):e0130605. PubMed ID: 26121582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a cell-based nonradioactive glucose uptake assay system for SGLT1 and SGLT2.
    Kanwal A; Singh SP; Grover P; Banerjee SK
    Anal Biochem; 2012 Oct; 429(1):70-5. PubMed ID: 22796500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1.
    Balteau M; Tajeddine N; de Meester C; Ginion A; Des Rosiers C; Brady NR; Sommereyns C; Horman S; Vanoverschelde JL; Gailly P; Hue L; Bertrand L; Beauloye C
    Cardiovasc Res; 2011 Nov; 92(2):237-46. PubMed ID: 21859816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy.
    Banerjee SK; Wang DW; Alzamora R; Huang XN; Pastor-Soler NM; Hallows KR; McGaffin KR; Ahmad F
    J Mol Cell Cardiol; 2010 Oct; 49(4):683-92. PubMed ID: 20600102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal absorption of glucose in mice as determined by positron emission tomography.
    Sala-Rabanal M; Ghezzi C; Hirayama BA; Kepe V; Liu J; Barrio JR; Wright EM
    J Physiol; 2018 Jul; 596(13):2473-2489. PubMed ID: 29707805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective SGLT2 inhibition by tofogliflozin reduces renal glucose reabsorption under hyperglycemic but not under hypo- or euglycemic conditions in rats.
    Nagata T; Fukazawa M; Honda K; Yata T; Kawai M; Yamane M; Murao N; Yamaguchi K; Kato M; Mitsui T; Suzuki Y; Ikeda S; Kawabe Y
    Am J Physiol Endocrinol Metab; 2013 Feb; 304(4):E414-23. PubMed ID: 23249697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of phlorizin binding domains in sodium-glucose cotransporter family: SGLT1 as a unique model system.
    Raja M; Kinne RK
    Biochimie; 2015 Aug; 115():187-93. PubMed ID: 26086341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Na+-D-glucose cotransporter: no role in insulin-mediated glucose uptake.
    Kolka CM; Rattigan S; Richards SM; Barrett EJ; Clark MG
    Horm Metab Res; 2005 Nov; 37(11):657-61. PubMed ID: 16308832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of SGLT1 and SGLT2 inhibitors.
    Rieg T; Vallon V
    Diabetologia; 2018 Oct; 61(10):2079-2086. PubMed ID: 30132033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic modeling of the effect of an sodium-glucose cotransporter inhibitor, phlorizin, on renal glucose transport in rats.
    Yamaguchi K; Kato M; Suzuki M; Asanuma K; Aso Y; Ikeda S; Ishigai M
    Drug Metab Dispos; 2011 Oct; 39(10):1801-7. PubMed ID: 21712434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the intestinal sodium-coupled glucose transporter 1 (SGLT1) by extracts and polyphenols from apple reduces postprandial blood glucose levels in mice and humans.
    Schulze C; Bangert A; Kottra G; Geillinger KE; Schwanck B; Vollert H; Blaschek W; Daniel H
    Mol Nutr Food Res; 2014 Sep; 58(9):1795-808. PubMed ID: 25074384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What does sodium-glucose co-transporter 1 inhibition add: Prospects for dual inhibition.
    Dominguez Rieg JA; Rieg T
    Diabetes Obes Metab; 2019 Apr; 21 Suppl 2(Suppl 2):43-52. PubMed ID: 31081587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fluorescence method for measurement of glucose transport in kidney cells.
    Blodgett AB; Kothinti RK; Kamyshko I; Petering DH; Kumar S; Tabatabai NM
    Diabetes Technol Ther; 2011 Jul; 13(7):743-51. PubMed ID: 21510766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent Sodium/Glucose Cotransporter SGLT1/2 Dual Inhibition Improves Glycemic Control Without Marked Gastrointestinal Adaptation or Colonic Microbiota Changes in Rodents.
    Du F; Hinke SA; Cavanaugh C; Polidori D; Wallace N; Kirchner T; Jennis M; Lang W; Kuo GH; Gaul MD; Lenhard J; Demarest K; Ajami NJ; Liang Y; Hornby PJ
    J Pharmacol Exp Ther; 2018 Jun; 365(3):676-687. PubMed ID: 29674332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SGLT1 contributes to glucose-mediated exacerbation of ischemia-reperfusion injury in ex vivo rat heart.
    Almalki A; Arjun S; Harding I; Jasem H; Kolatsi-Joannou M; Jafree DJ; Pomeranz G; Long DA; Yellon DM; Bell RM
    Basic Res Cardiol; 2024 Oct; 119(5):733-749. PubMed ID: 39088085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of SGLT1 in high glucose level-induced MMP-2 expression in human cardiac fibroblasts.
    Meng L; Uzui H; Guo H; Tada H
    Mol Med Rep; 2018 May; 17(5):6887-6892. PubMed ID: 29512713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels.
    Suga T; Kikuchi O; Kobayashi M; Matsui S; Yokota-Hashimoto H; Wada E; Kohno D; Sasaki T; Takeuchi K; Kakizaki S; Yamada M; Kitamura T
    Mol Metab; 2019 Jan; 19():1-12. PubMed ID: 30416006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.